Holds one valid CEP for betahistine, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one valid CEP for betahistine, filing since 2024. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for betahistine, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for betahistine. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one valid CEP for betahistine, filing since 2023.
Registered with SFDA (Saudi Arabia) for betahistine. Its 2023 FDA inspection closed as VAI.
Registered with SFDA (Saudi Arabia) for betahistine.
Registered with SFDA (Saudi Arabia) for betahistine.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Betahistine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free